Boddy JL - Search Results

1

The role of cell-free DNA size distribution in the management of prostate cancer.

Boddy JL, Gal S, Malone PR, Shaida N, Wainscoat JS, Harris AL. Boddy JL, et al. Oncol Res. 2006;16(1):35-41. doi: 10.3727/000000006783981297. Oncol Res. 2006. PMID: 16783966

2

Intra-individual variation of serum prostate specific antigen levels in men with benign prostate biopsies.

Boddy JL, Dev S, Pike DJ, Malone PR. Boddy JL, et al. BJU Int. 2004 Apr;93(6):735-8. doi: 10.1111/j.1464-410X.2003.04717.x. BJU Int. 2004. PMID: 15049982

3

An elevated PSA, which normalizes, does not exclude the presence of prostate cancer.

Boddy JL, Pike DJ, Al-Hayek S, Shaida N, Malone PR. Boddy JL, et al. Prostate Cancer Prostatic Dis. 2005;8(4):349-52. doi: 10.1038/sj.pcan.4500819. Prostate Cancer Prostatic Dis. 2005. PMID: 16010283

4

A seven-year follow-up of men following a benign prostate biopsy.

Boddy JL, Pike DJ, Malone PR. Boddy JL, et al. Eur Urol. 2003 Jul;44(1):17-20. doi: 10.1016/s0302-2838(03)00205-7. Eur Urol. 2003. PMID: 12814670

5

Prospective study of quantitation of plasma DNA levels in the diagnosis of malignant versus benign prostate disease.

Boddy JL, Gal S, Malone PR, Harris AL, Wainscoat JS. Boddy JL, et al. Clin Cancer Res. 2005 Feb 15;11(4):1394-9. doi: 10.1158/1078-0432.CCR-04-1237. Clin Cancer Res. 2005. PMID: 15746038

6

Expression of BNIP3 correlates with hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha and the androgen receptor in prostate cancer and is regulated directly by hypoxia but not androgens in cell lines.

Shaida N, Launchbury R, Boddy JL, Jones C, Campo L, Turley H, Kanga S, Banham AH, Malone PR, Harris AL, Fox SB. Shaida N, et al. Among authors: boddy jl. Prostate. 2008 Feb 15;68(3):336-43. doi: 10.1002/pros.20707. Prostate. 2008. PMID: 18163427

7

The androgen receptor is significantly associated with vascular endothelial growth factor and hypoxia sensing via hypoxia-inducible factors HIF-1a, HIF-2a, and the prolyl hydroxylases in human prostate cancer.

Boddy JL, Fox SB, Han C, Campo L, Turley H, Kanga S, Malone PR, Harris AL. Boddy JL, et al. Clin Cancer Res. 2005 Nov 1;11(21):7658-63. doi: 10.1158/1078-0432.CCR-05-0460. Clin Cancer Res. 2005. PMID: 16278385

8

Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the androgen receptor in prostate cancer but is not directly regulated by androgens or hypoxia.

Banham AH, Boddy J, Launchbury R, Han C, Turley H, Malone PR, Harris AL, Fox SB. Banham AH, et al. Prostate. 2007 Jul 1;67(10):1091-8. doi: 10.1002/pros.20583. Prostate. 2007. PMID: 17477366

9

Efficacy and complications of intravesical BCG in immunocompromised patients.

Hanna L, Ubee SS, Boddy J, Cooke PW. Hanna L, et al. BJU Int. 2014 May;113(5):691-3. doi: 10.1111/bju.12562. BJU Int. 2014. PMID: 24224546 No abstract available.

10

Early stent removal after pyeloplasty.

Boddy JL. Boddy JL. BJU Int. 2014 Jun;113(6):846-7. doi: 10.1111/bju.12734. BJU Int. 2014. PMID: 24905657 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters